Morphologic Study of the Intersegmental Plane After Fully Thoracoscopic Segmentectomy
NCT ID: NCT03227380
Last Updated: 2017-07-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2017-03-31
2018-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Thoracic Ultrasound in Monitoring Pleural Drainage in Postoperative Thoracic Surgery
NCT05545566
Safety of Early Removal of Chest Tubes After Thoracoscopic Lung Biopsies
NCT02727218
Establishment of a Prognosis Prediction Model and Scoring Criteria of Pulmonary Contusion Caused by Severe Thoracic Trauma
NCT04518904
Evaluation of Visceral Pleural Lumbar Lymphatic Drainage
NCT03628326
Intraoperative Ultrasonographic Localization of Pulmonary Nodules in VATS
NCT03599505
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
One of the challenges in the development of the thoracoscopic segmentectomy technique we have published (2-5) is the orientation (6-7) and the division of the intersegmental plane, by contrast to segmentectomy by thoracotomy where this is helped by palpation and the manual traction which can be used on the segment, along the intersegmental vein. The most commonly used technique to separate two adjacent segments remains stapling, despite its high cost and sometimes giving a less anatomical section, with a risk to encroach on the intersegmental vein. Moreover, there can be a partial plicator of the spared segment(s) which could in theory make them less functional.
We have however shown that the postoperative morbidity and mortality rates were much lower than that of patients who had a thoracotomy, dropping from 42% for thoracotomies to 16% for thoracoscopies, the surgical approach being an independent predictive factor for postoperative complications (8).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
radiological evaluation
to explore by thoracic densitometry with contrast the spared segments after stapling of the intersegmental plan following a thoracoscopic segmentectomy
thoracic densitometry with contrast
injected CT scan at 3 or 6 months after segmentectomy VATS
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
thoracic densitometry with contrast
injected CT scan at 3 or 6 months after segmentectomy VATS
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Men or women aged 18 years or greater
* Absence of severe hepatic insufficiency
* signed and dated informed consent
* candidate for segmentectomy
* Registration in a national healthcare system.
* Women of child-bearing age using effective oral or barrier contraception
Exclusion Criteria
* Know allergy or non-controlled asthma - pregnancy
* Severe hepatic insufficiency (creatinine clearance \< 30ml/min, by Cockroft's method)
* Pregnant or breastfeeding women
* Patients under trusteeship or curators
* Diabetic patients or patients receiving oral antidiabetic medication
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut Mutualiste Montsouris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut Mutualiste montsouris
Paris, , France
Institut mutualiste montsouris
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Isabelle SAURET
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
THO-2016-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.